The U.S. Food and Drug Administration today approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. The drug is being manufactured by GlaxoSmithKline, so maybe the drugs will soon be available in Nigeria since the company has it's presence here. Now HIV victims can heave a sigh of relief. Follow @gidiLink
